Procedure for Stability Testing of Complex Generic Drugs

1) Purpose

The purpose of this SOP is to establish a procedure for conducting stability studies for complex generic drug products in compliance with US FDA guidelines. This ensures that these products meet all required standards of quality, safety, and efficacy throughout their shelf life.

2) Scope

This SOP applies to all personnel involved in the stability testing of complex generic drug products, including formulation development, quality control, and regulatory affairs teams.

3) Responsibilities

Formulation Development Team: Responsible for developing the generic formulation and selecting suitable packaging materials.
Stability Study Team: Responsible for conducting stability studies according to approved protocols.
Quality Assurance Team: Responsible for ensuring data accuracy and compliance with FDA guidelines.

4) Procedure

4.1 Protocol Development

4.1.1 Develop a stability testing protocol that meets US FDA guidelines for complex generics.

4.1.2 Define parameters such

as dissolution, assay, impurity profile, and physical characteristics.

4.2 Sample Preparation and Storage

4.2.1 Prepare samples in their final packaging for testing.

4.2.2 Store samples under specified conditions (e.g., room temperature, accelerated) for stability studies.

4.3 Conducting Stability Tests

4.3.1 Conduct stability tests at all required intervals (e.g., 0, 3, 6, 9, 12 months).

4.3.2 Document all data